TY - JOUR
T1 - Determining the Plasmodium vivax VCG-1 strain blood stage proteome
AU - Moreno-Pérez, D. A.
AU - Dégano, R.
AU - Ibarrola, N.
AU - Muro, A.
AU - Patarroyo, M. A.
N1 - Funding Information:
We would like to thank Alvaro Mongui for the experimental design, Diego Alonso Lopez and Carlos Fernando Suárez for bioinformatics support, Jason Garry for translating and reviewing this manuscript and especially Professor Manuel Elkin Patarroyo for his invaluable comments and suggestions. We would also like to thank the ProteoRed, PRB2-ISCIII proteomics facility at the Instituto de Biología Molecular y Celular del Cáncer USAL-CSIC, financed by grant PT13/0001. This research was supported by the “ Instituto Colombiano para el Desarrollo de la Ciencia ‘Francisco José de Caldas ’” (COLCIENCIAS) through contracts RC#309-2013 and 709-2013 .
Publisher Copyright:
© 2014 .
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2015/1/5
Y1 - 2015/1/5
N2 - Plasmodium vivax is the second most prevalent parasite species causing malaria in humans living in tropical and subtropical areas throughout the world. There have been few P. vivax proteomic studies to date and they have focused on using clinical isolates, given the technical difficulties concerning how to maintain an in vitro culture of this species. This study was thus focused on identifying the P. vivax VCG-1 strain proteome during its blood lifecycle through LC-MS/MS; this led to identifying 734 proteins, thus increasing the overall number reported for P. vivax to date. Some of them have previously been related to reticulocyte invasion, parasite virulence and growth and others are new molecules possibly playing a functional role during metabolic processes, as predicted by Database for Annotation, Visualization and Integrated Discovery (DAVID) functional analysis. This is the first large-scale proteomic analysis of a P. vivax strain adapted to a non-human primate model showing the parasite protein repertoire during the blood lifecycle. Database searches facilitated the in silico prediction of proteins proposed for evaluation in further experimental assays regarding their potential as pharmacologic targets or as component of a totally efficient vaccine against malaria caused by P. vivax. Biological significance: P. vivax malaria continues being a public health problem around world. Although considerable progress has been made in understanding genome- and transcriptome-related P. vivax biology, there are few proteome studies, currently representing only 8.5% of the predicted in silico proteome reported in public databases. A high-throughput proteomic assay was used for discovering new P. vivax intra-reticulocyte asexual stage molecules taken from parasites maintained in vivo in a primate model. The methodology avoided the main problem related to standardising an in vitro culture system to obtain enough samples for protein identification and annotation. This study provides a source of potential information contributing towards a basic understanding of P. vivax biology related to parasite proteins which are of significant importance for the malaria research community.
AB - Plasmodium vivax is the second most prevalent parasite species causing malaria in humans living in tropical and subtropical areas throughout the world. There have been few P. vivax proteomic studies to date and they have focused on using clinical isolates, given the technical difficulties concerning how to maintain an in vitro culture of this species. This study was thus focused on identifying the P. vivax VCG-1 strain proteome during its blood lifecycle through LC-MS/MS; this led to identifying 734 proteins, thus increasing the overall number reported for P. vivax to date. Some of them have previously been related to reticulocyte invasion, parasite virulence and growth and others are new molecules possibly playing a functional role during metabolic processes, as predicted by Database for Annotation, Visualization and Integrated Discovery (DAVID) functional analysis. This is the first large-scale proteomic analysis of a P. vivax strain adapted to a non-human primate model showing the parasite protein repertoire during the blood lifecycle. Database searches facilitated the in silico prediction of proteins proposed for evaluation in further experimental assays regarding their potential as pharmacologic targets or as component of a totally efficient vaccine against malaria caused by P. vivax. Biological significance: P. vivax malaria continues being a public health problem around world. Although considerable progress has been made in understanding genome- and transcriptome-related P. vivax biology, there are few proteome studies, currently representing only 8.5% of the predicted in silico proteome reported in public databases. A high-throughput proteomic assay was used for discovering new P. vivax intra-reticulocyte asexual stage molecules taken from parasites maintained in vivo in a primate model. The methodology avoided the main problem related to standardising an in vitro culture system to obtain enough samples for protein identification and annotation. This study provides a source of potential information contributing towards a basic understanding of P. vivax biology related to parasite proteins which are of significant importance for the malaria research community.
UR - http://www.scopus.com/inward/record.url?scp=84908316303&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908316303&partnerID=8YFLogxK
U2 - 10.1016/j.jprot.2014.10.003
DO - 10.1016/j.jprot.2014.10.003
M3 - Research Article
AN - SCOPUS:84908316303
SN - 1874-3919
VL - 113
SP - 268
EP - 280
JO - Journal of Proteomics
JF - Journal of Proteomics
ER -